13F reference period
Q2 2026
Security Snapshot
MYRIAD GENETICS INC - Common Stock (MYGN) Institutional Ownership
CUSIP: 62855J104
13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026
Institutions Reporting
195
Shares (Excl. Options)
89,049,039
Price
$5.71
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- MYGN on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 89,049,039
- Total 13F value
- $508,313,628
- Portfolio coverage rank
- 0%
- Share change
- +1,018,680
- Value change
- +$20,085,753
- Number of holders
- 195
- Shares outstanding
- 95,201,317
- SEC-reported price per share
- $4.31
- Insider filing price
- $4.31
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- MYGN - MYRIAD GENETICS INC - Common Stock is tracked under CUSIP 62855J104.
- 195 institutions reported positions in Q2 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 203 to 195 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $397,037,050 to $508,313,628.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 195 institutions filings for Q2 2026.
Security key
62855J104
13F reference period
Q2 2026
13F holders
195
13D/G owners
8
CIK / CUSIP context first
Open Q2 2026 holders
MYGN full holder history
MYRIAD GENETICS INC SEC filings
MYRIAD GENETICS INC company facts
MYRIAD GENETICS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 62855J104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
MYGN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 10% | $31,385,970 | 9,900,937 | BlackRock Portfolio Management LLC | 31 Aug 2026 | |||
| BlackRock, Inc. | 8.5% | -45% | $35,894,329 | -$27,581,033 | 7,976,163 | -43% | BlackRock, Inc. | 31 Mar 2026 |
| INTEGRATED CORE STRATEGIES (US) LLC | 7.2% | +42% | $41,205,972 | +$12,003,761 | 6,700,158 | +41% | Millennium Management LLC | 31 Dec 2025 |
| Vestal Point Capital, LP | 6.1% | $33,607,100 | 5,735,000 | Vestal Point Capital, LP | 30 Jun 2026 | |||
| STATE STREET CORP | 5.3% | +12% | $29,212,452 | +$3,287,653 | 4,985,060 | +13% | STATE STREET CORPORATION | 30 Jun 2026 |
| BARCLAYS PLC | 4.2% | -22% | $28,480,691 | -$6,945,955 | 3,939,238 | -20% | Barclays PLC | 30 Sep 2025 |
| Camber Capital Management LP | 3.4% | $22,320,000 | 3,100,000 | Camber Capital Management LP | 31 Dec 2024 | |||
| DISCIPLINED GROWTH INVESTORS INC /MN | 0.8% | -86% | $4,244,772 | -$19,924,683 | 753,956 | -82% | DISCIPLINED GROWTH INVESTORS INC /MN | 30 Jun 2025 |
As of 30 Jun 2026, 195 institutional investors reported holding 89,049,039 shares of MYRIAD GENETICS INC - Common Stock (MYGN). This represents 94% of the company’s total 95,201,317 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
76%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | 10,890,440 | +23% | 0% | $62,184,412 |
| MILLENNIUM MANAGEMENT LLC | 7% | 6,620,372 | -0.73% | 0.03% | $37,802,324 |
| Vestal Point Capital, LP | 6% | 5,735,000 | +248% | 0.77% | $32,746,850 |
| STATE STREET CORP | 5.2% | 4,985,060 | +13% | 0% | $28,464,693 |
| D. E. Shaw & Co., Inc. | 4.8% | 4,582,083 | +1.8% | 0.02% | $26,163,694 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 4,081,376 | +4% | 0% | $23,304,657 |
| ACADIAN ASSET MANAGEMENT LLC | 3.3% | 3,126,973 | +35% | 0.02% | $17,840,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.2% | 3,079,670 | +19% | 0% | $17,584,916 |
| AQR CAPITAL MANAGEMENT LLC | 2.9% | 2,766,689 | +45% | 0.01% | $15,797,792 |
| MORGAN STANLEY | 2.6% | 2,481,104 | -22% | 0% | $14,167,103 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 2,416,197 | +4.2% | 0% | $13,800,073 |
| GOLDMAN SACHS GROUP INC | 2.2% | 2,056,843 | -13% | 0% | $11,744,574 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2% | 1,891,527 | -9.4% | 0.04% | $10,800,619 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.8% | 1,740,794 | -3.4% | 0% | $9,939,934 |
| Qube Research & Technologies Ltd | 1.7% | 1,665,835 | -1.5% | 0.01% | $9,511,918 |
| FEDERATED HERMES, INC. | 1.6% | 1,570,314 | -21% | 0.01% | $8,966,493 |
| TWO SIGMA INVESTMENTS, LP | 1.6% | 1,557,727 | +21% | 0.01% | $8,894,621 |
| Nuveen, LLC | 1.6% | 1,545,549 | +68% | 0% | $8,825,085 |
| MACKENZIE FINANCIAL CORP | 1.6% | 1,535,702 | 0.01% | $8,768,858 | |
| CITADEL ADVISORS LLC | 1.6% | 1,533,684 | +239% | 0.01% | $8,757,335 |
| Connor, Clark & Lunn Investment Management Ltd. | 1.5% | 1,407,860 | +6.8% | 0.02% | $8,038,880 |
| Aberdeen Group plc | 1.4% | 1,308,933 | +18% | 0.01% | $7,474,007 |
| MARSHALL WACE, LLP | 1.3% | 1,222,804 | +11% | 0.01% | $6,982,210 |
| DIMENSIONAL FUND ADVISORS LP | 1.1% | 1,051,996 | +42% | 0% | $6,008,336 |
| Assenagon Asset Management S.A. | 1.1% | 1,031,464 | -29% | 0.01% | $5,889,659 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 1,090,156 | $4,694,170 | -$1,264,080 | $4.31 | 21 |
| 2026 Q2 | 89,049,039 | $508,313,628 | +$20,085,753 | $5.71 | 195 |
| 2026 Q1 | 88,214,179 | $397,037,050 | -$20,263,680 | $4.50 | 203 |
| 2025 Q4 | 92,194,007 | $567,141,060 | +$27,455,645 | $6.15 | 220 |
| 2025 Q3 | 88,492,355 | $639,685,484 | +$7,333,020 | $7.23 | 215 |
| 2025 Q2 | 90,529,530 | $480,755,771 | -$73,903,588 | $5.31 | 216 |
| 2025 Q1 | 93,969,029 | $833,362,943 | +$10,158,296 | $8.87 | 226 |
| 2024 Q4 | 92,375,178 | $1,266,992,283 | -$38,609,730 | $13.71 | 215 |
| 2024 Q3 | 90,691,605 | $2,483,201,789 | -$46,730,979 | $27.39 | 242 |
| 2024 Q2 | 92,267,243 | $2,256,709,187 | -$39,028,941 | $24.46 | 222 |
| 2024 Q1 | 93,842,572 | $2,001,184,496 | +$85,643,654 | $21.32 | 185 |
| 2023 Q4 | 89,898,458 | $1,720,778,542 | +$139,092,939 | $19.14 | 193 |
| 2023 Q3 | 82,696,930 | $1,326,499,466 | +$18,782,858 | $16.04 | 184 |
| 2023 Q2 | 81,069,882 | $1,879,159,822 | -$25,379,016 | $23.18 | 184 |
| 2023 Q1 | 82,216,167 | $1,909,846,418 | +$45,174,636 | $23.23 | 186 |
| 2022 Q4 | 80,553,035 | $1,168,812,560 | -$19,067,888 | $14.51 | 191 |
| 2022 Q3 | 81,539,353 | $1,555,961,809 | +$26,155,420 | $19.08 | 184 |
| 2022 Q2 | 79,888,231 | $1,451,741,809 | +$19,085,207 | $18.17 | 185 |
| 2022 Q1 | 78,868,034 | $1,987,215,536 | +$13,382,979 | $25.20 | 198 |
| 2021 Q4 | 78,283,503 | $2,159,672,726 | -$41,784,396 | $27.60 | 191 |
| 2021 Q3 | 79,271,409 | $2,560,639,030 | +$122,124,573 | $32.29 | 208 |
| 2021 Q2 | 75,479,842 | $2,308,615,173 | +$49,345,949 | $30.58 | 198 |
| 2021 Q1 | 73,860,328 | $2,248,603,947 | -$35,142,715 | $30.45 | 193 |
| 2020 Q4 | 74,996,999 | $1,483,013,849 | +$38,048,718 | $19.78 | 176 |
| 2020 Q3 | 78,424,909 | $1,022,586,628 | +$19,999,510 | $13.04 | 185 |